Notably, while tetraspanins were often used as markers for sEVs, significant signals in CD63 and CD9 were detected in cancer cell-derived m/lEVs, suggesting that these molecules are not unique markers for sEVs, as the MISEV 2018 guidelines stated [24]. The gene discussed is CD63; the disease is cancer.